Recruitment

Recruitment Status
Terminated

Exclusion Criteria

allergy to contrast media
refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
...
allergy to contrast media
refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
life expectancy < 6 months
pregnancy
the lesion cannot be accessed with the wire guide
severe kidney disease (creatinine clearance < 30 mL min)
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)

Summary

Conditions
  • Deep Vein Thrombosis
  • Venous Thromboembolism
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Exclusion Criteria

allergy to contrast media
refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
...
allergy to contrast media
refusal to provide informed consent or inability to follow up
prior history of ipsilateral DVT or femoral catheters
life expectancy < 6 months
pregnancy
the lesion cannot be accessed with the wire guide
severe kidney disease (creatinine clearance < 30 mL min)
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)

Tracking Information

NCT #
NCT02066597
Collaborators
Not Provided
Investigators
  • Principal Investigator: Esteban Gandara, MD OHRI
  • Esteban Gandara, MD OHRI